Incidence of genetic abnormalities in patients with primary hypereosinophilia

Siriraj Hospital Mahidol University0 sites151 target enrollmentMay 14, 2021

Overview

Phase: N/A
Intervention: Not specified
Conditions: The patient 18 years and older ,The patients diagnosed with primary hypereosinophilia leukocyte count more than 1,500 per microliter for a period of more than 1 month.
Sponsor: Siriraj Hospital Mahidol University
Enrollment: 151
Status: Recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

May 14, 2021

End Date

December 30, 2023

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

Siriraj Hospital Mahidol University

•1\) The patients diagnosed with primary hypereosinophilia type white blood cells greater than 1,500 per microliter for a period of more than 1 month
•2\) 18 years of age and over
•3\) Patients who received the gene test The specific targeted fusion gene panel with hypereosinophilia
•4\) was welcomed to join the program by signing.

•1\.The patient was detected from a bacterial infection by antibody detection Research projects in which patients are examined. Incidence of nasopharyngeal carcinoma in patients primary hypereosinophilias 686 / 2563 (IRB2\)
•2\.Patients with allergic history
•3\.Asthma patients
•4\. Patients with immune diseases
•5 Patients diagnosed with various cancers are not in peacetime.
•6\. History of steroid use in patients with herbs or drugs in the past three months
•7\. The patients had a history of adverse events leading to leukocyte disease, hypertension, and xa0;
•Penicillin, cephalosporin, GM\-CSF, NSAID, ranitidine, isopropanol, isopropanol, alanine, amazillin sulfate, chlorazine, chlorazine Cyclospora